Literature DB >> 9707605

Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response.

M R Ehrenstein1, T L O'Keefe, S L Davies, M S Neuberger.   

Abstract

Accelerated development of the secondary immune response may be attributable in part to the rapid delivery of antigen to lymphoid follicles by circulating antibody elicited on primary immunization. Here we provide evidence indicating that the nonspecific IgM present in naive mice (natural antibody) plays a role in the acceleration of the primary response. Targeted deletion of the Ig microseconds polyadenylation site by use of Cre recombinase allowed the creation of mice that, although harboring a normal number of B cells expressing surface IgM, completely lacked serum IgM while retaining the other Ig isotypes. These mice retained a broadly normal B lymphocyte distribution (although containing a somewhat expanded peritoneal B1a subset) but exhibited substantial delays in mounting affinity-matured IgG responses to T cell-dependent antigens. The T cell-independent response, however, was augmented. The data indicate that the IgM present before antigen challenge (as well, possibly, as that elicited immediately after immunization) accelerates maturation of the primary response, presumably by complexing with the antigen and facilitating lymphocyte activation and/or antigen trapping.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707605      PMCID: PMC21466          DOI: 10.1073/pnas.95.17.10089

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.

Authors:  D T Fearon; R H Carter
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

2.  Hyperresponsive B cells in CD22-deficient mice.

Authors:  T L O'Keefe; G T Williams; S L Davies; M S Neuberger
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

Review 3.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

4.  Role of complement in induction of the allergic response.

Authors:  M B Pepys
Journal:  Nat New Biol       Date:  1972-05-31

Review 5.  Natural antibodies and the immune response.

Authors:  S V Boyden
Journal:  Adv Immunol       Date:  1966       Impact factor: 3.543

6.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.

Authors:  J M Ahearn; M B Fischer; D Croix; S Goerg; M Ma; J Xia; X Zhou; R G Howard; T L Rothstein; M C Carroll
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

Review 7.  Germinal centers and their role in immune responses.

Authors:  G Thorbecke; S P Lerman
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

8.  II. IgM-mediated enhancement: dependency on antigen dose, T-cell requirement and lack of evidence for an idiotype-related mechanism.

Authors:  P Lehner; P Hutchings; P M Lydyard; A Cooke
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

9.  Regulation of thymus-independent responses: unresponsiveness to a second challenge of TNP-Ficoll is mediated by hapten-specific antibodies.

Authors:  P H Brodeur; H H Wortis
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

10.  Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors.

Authors:  L A Herzenberg; S J Black; T Tokuhisa; L A Herzenberg
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  78 in total

1.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Authors:  M Boes; T Schmidt; K Linkemann; B C Beaudette; A Marshak-Rothstein; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Functions of antibodies in the regulation of B cell responses in vivo.

Authors:  B Heyman
Journal:  Springer Semin Immunopathol       Date:  2001-12

3.  Sequence-specific binding of normal serum immunoglobulin M to exposed protein C-termini.

Authors:  Alex V Sokoloff; Marissa Puckett; James J Ludtke; Bryan Fetterly
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

Review 4.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 5.  Natural serum IgM maintains immunological homeostasis and prevents autoimmunity.

Authors:  Jessica J Manson; Claudia Mauri; Michael R Ehrenstein
Journal:  Springer Semin Immunopathol       Date:  2004-12-21

6.  The acquisition of narrow binding specificity by polyspecific natural IgM antibodies in a semi-physiological environment.

Authors:  Qili Chu; James J Ludtke; Vladimir M Subbotin; Andrey Blockhin; Alex V Sokoloff
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

7.  Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer.

Authors:  Ben J C Quah; Vaughan P Barlow; Virginia McPhun; Klaus I Matthaei; Mark D Hulett; Christopher R Parish
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

Review 8.  The who, how and where of antigen presentation to B cells.

Authors:  Facundo D Batista; Naomi E Harwood
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

9.  FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Authors:  Sudhir Gupta; Sudhanshu Agrawal; Sastry Gollapudi; Hiromi Kubagawa
Journal:  Hum Immunol       Date:  2016-10-14       Impact factor: 2.850

10.  Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease.

Authors:  H E Baxendale; M Johnson; R C M Stephens; J Yuste; N Klein; J S Brown; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.